Brian Bloom

Brian Bloom is a prominent figure in the healthcare and biotechnology investment sector. He is the co-founder, Chairman, and Chief Executive Officer of Bloom Burton & Co., a specialized healthcare investment banking and advisory firm.1

Professional Background

Brian has extensive experience in the healthcare and biotechnology industries. Before co-founding Bloom Burton in 2008, he spent six years at Dundee Securities in healthcare and biotechnology institutional sales and equity research. His career began at New York-based investment banking firms SCO Financial Group and Molecular Securities.1

Education and Achievements

Brian holds an Honours Bachelor of Science in Biochemistry from McMaster University. He also studied at the Mount Sinai Graduate School for Biological Sciences of New York University, focusing on molecular endocrinology and biophysics.1 In recognition of his contributions, Brian received the McMaster University 2017 Distinguished Alumni Award in Science.1

Role at Triumvira Immunologics

Brian Bloom serves as a Board Observer at Triumvira Immunologics, Inc., a biotechnology company.23 In March 2022, he shared news about Triumvira completing an extension of their Series A financing, bringing the total round to approximately $100 million.4

Other Board Positions

Brian's expertise is sought after in various capacities within the life sciences sector. He currently serves on the Board of Directors of Satellos Bioscience and Appili Therapeutics. Previously, he was the Chairman of the Board of Grey Wolf Animal Health and Triumvira Immunologics.1

Brian Bloom's LinkedIn username is brian-bloom-0521983b, as mentioned in the query.